Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

December 3, 2019June 17, 2020

Keytruda Shows Promise for Some with Highly Advanced Prostate Cancer in Phase 2 Trial

News

The immunotherapy Keytruda (pembrolizumab) extended for at least two years the lives of a small proportion of men with metastatic castration-resistant prostate cancer (mCRPC) who had exhausted all other treatment options, data from ... Read more

November 11, 2019

Men with BRCA2 Mutations Should Get Regular PSA Screening, Phase 3 Interim Data Suggest

News

Prostate-specific antigen (PSA) testing — a controversial approach to detecting prostate cancer — spotted the cancer more often, at a younger age, and in more serious forms in men older ... Read more

October 31, 2019

Prostate Cancer Patients May Benefit from Routine Tumor Genetic Testing, Study Suggests

News

Implementation of routine tumor genetic testing may help identify the approximately 30% of men with metastatic castration-resistant prostate cancer (mCRPC) who may significantly benefit from targeted treatment, namely PARP inhibitors, ... Read more

August 13, 2018August 14, 2018

3 in 4 Men with Slow-growing Prostate Cancer Fail to Get Appropriate Follow-up, Study Finds

News

Nearly three-quarters of men with slow-growing prostate cancer who decide on active surveillance are not receiving the appropriate follow-up and might be missing signs of tumor worsening, according to a recent ... Read more

July 5, 2018July 10, 2018

Xtandi May Not Improve Overall Survival in Specific Type of Prostate Cancer, Early Phase 3 Data Suggest

News

Treatment with Xtandi (enzalutamide) does not seem to improve overall survival in men with non-metastatic castration-resistant prostate cancer (CRPC), according to the first interim analysis of a Phase 3 clinical trial. These findings were published in ... Read more

May 10, 2018

Google Develops Augmented Reality Microscope to Better Detect Cancer

News

Google AI researchers developed an artificial intelligence (AI) system that can accurately detect cancer — prostate and breast cancer so far — in a standard microscope in real time. Besides ... Read more

February 28, 2018March 1, 2018

Consuming Alcohol After Prostate Cancer Diagnosis is Detrimental, Canadian Study Says

News

Alcohol consumption after prostate cancer diagnosis is associated with reduced prostate cancer-specific survival, specifically in men who consume more than two drinks per day, according to a Canadian study. The ... Read more

January 12, 2018January 12, 2018

Mediterranean Diet Reduces Risk of Aggressive Prostate Cancer, Study Says

News

Men who follow a Mediterranean diet — rich in fruits, vegetables, legumes, fish, boiled potatoes, olives, and vegetable oil — have a lower risk of aggressive prostate cancer, a Spanish ... Read more

January 9, 2018January 9, 2018

New Way to Preserve Tumor Biomarkers in Blood Could Lead to Better Treatment Decisions

News

Massachusetts General Hospital researchers have come up with a way to prolong the life of cancer cells circulating in the bloodstream. Tests in prostate cancer patients indicated that the breakthrough could ... Read more

December 14, 2017

Researchers Identify Potential Therapeutic Target for Advanced Prostate Cancer

News

Researchers in Spain studying the 3D structure of the androgen receptor have identified a key protein for its activation called TFIIF, making it a possible therapeutic target for advanced prostate ... Read more